Clinical trials
Resistance clinical trials
Below are recruiting resistance clinical trials, each written for real people, not researchers. We’re tracking 1,200 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07566832Recruiting
Strength Training and Inflammation in Older Adults
This study tests whether a specific type of strength training reduces inflammation in the body for adults aged 60–75. Researchers will measure how your body responds to this training over time.
TaipeiAges 60–75 - NCT06629779RecruitingPhase 3
Study of Mevrometostat for Advanced Prostate Cancer
This study tests a new drug called mevrometostat for men with a specific type of advanced prostate cancer that has spread and is still growing despite hormone therapy. It aims to see if the drug can help control the cancer.
Chandler, ArizonaAges 18 years+ - NCT06956911Enrolling by invitation
Low-resistance exercise with blood flow restriction after heart surgery
This trial tests if gentle arm exercises with a special blood pressure cuff can help men recover their lung function after heart surgery. It may be an option for those who are stable and ready to follow simple instructions.
Cairo, Cairo GovernorateAges 45–60 - NCT04704505RecruitingPhase 2
Testosterone-like treatment plus radium for bone-spread prostate cancer
This trial studies whether adding a testosterone-related therapy (BAT) to radium-223 can better control prostate cancer that has spread mainly to the bones. It may help shrink tumors in the bone and slow PSA rises, which are a common marker of prostate cancer activity.
Baltimore, MarylandAges 18 years+ - NCT07520409Recruiting
Exercise for Abdominal Separation After Pregnancy
This trial tests two types of exercises to help close the gap that forms between your abdominal muscles after pregnancy. The study compares a specific core exercise with ankle resistance to see which helps your abdominal muscles come back together more effectively.
Guiranwala, Punjab ProvinceAges 20–45 - NCT04388124RecruitingPhase 2
Test drug to block endothelin for hard-to-control blood pressure
This Phase 2 trial tests whether blocking endothelin (using bosentan and related treatments) can improve blood pressure in people with resistant hypertension—high blood pressure that stays high despite multiple medicines. It may help if your blood pressure is still above target even with the right combination of therapy.
RouenAges 18–80 - NCT06930027Enrolling by invitation
Low-oxygen training for ice hockey players
This study tests whether training in a low-oxygen environment (hypoxia) can boost strength and power in ice hockey players. Researchers want to see if it helps improve your explosive movements and muscle function.
Katowice, Silesian VoivodeshipAges 18–35 - NCT07321600Recruiting
Breathing muscle training with Schroth exercises for scoliosis in teens
This trial tests whether adding a special breathing exercise (inspiratory muscle training) to standard Schroth exercises improves breathing and posture in teenage girls with scoliosis. It may help strengthen the muscles used for breathing.
Kırşehir, MerkezAges 10–18 - NCT07365995RecruitingPhase 3
New drug for advanced prostate cancer vs. standard chemo
This trial tests a new drug called BNT324 against the standard chemotherapy docetaxel for men with advanced prostate cancer that has stopped responding to hormone therapy. It aims to see if the new treatment can help control the cancer better.
Aurora, ColoradoAges 18 years+ - NCT06924164Recruiting
Strength training for snapping hip syndrome
This trial tests if progressive strength training can reduce pain and snapping in adults with external snapping hip. If you have a snapping or popping sensation on the outside of your hip with discomfort, this study may help find a non-surgical treatment option.
AalborgAges 18–40 - NCT07307677Recruiting
Melatonin and metformin for PCOS with insulin resistance
This study tests if adding melatonin to metformin can improve insulin resistance and other health markers in women with PCOS who have insulin resistance. It compares the combination to metformin alone.
Dhaka, ShahbagAges 18–35 - NCT07287150RecruitingPhase 2
Inavolisib for metastatic castration-resistant prostate cancer
This trial tests a new drug called Inavolisib for men with a specific type of advanced prostate cancer that has stopped responding to hormone therapy. It aims to see if the drug can help slow the cancer's growth.
Los Angeles, CaliforniaAges 18 years+ - NCT06227156RecruitingPhase 2
Targeted drug for HER2-positive castration-resistant prostate cancer
This trial tests a new drug called Disitamab Vedotin for men with advanced prostate cancer that is no longer responding to hormone therapy. The drug targets a protein called HER2 on cancer cells to try to shrink or slow the cancer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06940037Recruiting
Aging biology and strength training in older adults
This study looks at how aging affects the way older adults respond to resistance training (exercises using weights or resistance bands). It compares two types of training to see which works better for improving mobility and strength.
Boston, MassachusettsAges 65 years+ - NCT07244341RecruitingPhase 1
Valemetostat and darolutamide for advanced prostate cancer
This trial tests a new combination of two drugs (valemetostat and darolutamide) for men with metastatic castration-resistant prostate cancer that has worsened after prior treatment. The goal is to see if the combination can slow cancer growth.
La Jolla, CaliforniaAges 18 years+ - NCT07234331Recruiting
Studying antibiotic resistance in nursing home residents
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
AngersAges 18 years+ - NCT06531499RecruitingPhase 1
Study of a radioactive drug for advanced prostate cancer
This trial tests an extended treatment with a radioactive drug (177Lu-PSMA-617) to see how the body handles it, how safe it is, and how well it works. It is for men with metastatic castration-resistant prostate cancer who have not had chemotherapy yet.
Los Angeles, CaliforniaAges 18–100 - NCT06533644RecruitingPhase 2
SYNC-T therapy study for advanced prostate cancer
This trial tests a new treatment called SYNC-T Therapy (SV-102) for men with metastatic castration-resistant prostate cancer that has progressed after other treatments. The therapy is given directly into a tumor to help your immune system fight the cancer.
Phoenix, ArizonaAges 18 years+ - NCT07632911Enrolling by invitation
How Exercise Affects Your Immune System
This study looks at how different types of exercise—aerobic (like running) and resistance (like weightlifting)—change how your immune system works. Researchers will track your immune health over time to understand which exercise style might boost immunity best.
MalatyaAges 18–35 - NCT05922124RecruitingPhase 4
Testing two antibiotics against resistant lung and bloodstream infections
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
HaifaAges 16 years+ - NCT07135102RecruitingPhase 1
Radioactive drug for advanced prostate cancer
This study tests an experimental radioactive drug ([225Ac]Ac-PSMA-XT) that targets prostate cancer cells. It is for men whose prostate cancer has spread and stopped responding to standard hormone therapy and chemotherapy.
Jinan, ShandongAges 18 years+ - NCT07240857Enrolling by invitationEarly Phase 1
CAR-T cell injection for advanced prostate cancer
This trial tests a new treatment called ACT#001 CAR-T cells, given as a local injection, for prostate cancer that has stopped responding to hormone therapy. It aims to see if this therapy is safe and can help shrink tumors.
Hangzhou, ZhejiangAges 18 years+ - NCT07525089Enrolling by invitation
Treatment to Clear Resistant Bacteria from Your Gut
This study tests whether a new treatment called BM111 can safely clear two types of antibiotic-resistant bacteria (CRE and VRE) that live in your intestines without causing infection. You'd provide stool samples over several weeks to see if the bacteria levels drop.
SeoulAges 19–65 - NCT07112807Recruiting
Shoulder blade exercise study: Sphere vs. Blade
This study compares two types of exercise (ShoulderSphere and Bodyblade) to improve shoulder blade movement. It is for people who have scapular dyskinesia but no current or recent shoulder pain.
AnkaraAges 18–25
Hear when a new Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for resistance?
- Yes. Clin2 currently lists 1,200 recruiting resistance studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a resistance trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a resistance trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.